Literature DB >> 6785523

Acute hereditary tyrosinaemia type I: clinical, biochemical and haematological studies in twins.

R G Gray, A D Patrick, F E Preston, M F Whitfield.   

Abstract

Affected twins with acute hereditary tyrosinaemia type I are described. Attempts at therapy with a phenylalanine-tyrosine-methionine restricted diet supplemented with cysteine, vitamin E and ascorbic acid failed to influence the course of the disorder. The bleeding diathesis was due to a morbid reduction of a number of clotting factors, particularly factor VII, and this was associated with impaired platelet aggregation and release. The liver of one showed a marked reduction in fumarylacetoacetate lyase activity and her urine contained a potent inhibitor of red cell delta-aminolaevulinic acid dehydratase. Biochemical investigations of cultured fibroblasts suggest that these do not express the disorder and are unlikely to prove useful diagnostically.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785523     DOI: 10.1007/BF02263580

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  NATURE OF PROTHROMBIN BIOSYNTHESIS: PREPROTHROMBINAEMIA IN VITAMIN K-DEFICIENCY.

Authors:  H C HEMKER; J J VELTKAMP; A HENSEN; E A LOELIGER
Journal:  Nature       Date:  1963-11-09       Impact factor: 49.962

2.  Abnormal platelet function and ultrastructure in fulminant hepatic failure.

Authors:  M H Rubin; M J Weston; G Bullock; J Roberts; P G Langley; Y S White; R Williams
Journal:  Q J Med       Date:  1977-07

3.  Evidence for the possible formation of a toxic tyrosine metabolite by the liver microsomal drug metabolizing system.

Authors:  J C David
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  The enzymatic deficiency in tyrosinemia.

Authors:  B N La Du
Journal:  Am J Dis Child       Date:  1967-01

5.  [Hereditary tyrosinemia. I. Clinical and biological study of 62 cases].

Authors:  J Larochelle; L Privé; M Bélanger; L Bélanger; M Tremblay; J C Claveau; G Aubin; D Paradis
Journal:  Pediatrie       Date:  1973 Jan-Feb

6.  Hepatic glycogen storage disease. Clinical and laboratory findings in 23 cases.

Authors:  J Spencer-Peet; M E Norman; B D Lake; J McNamara; A D Patrick
Journal:  Q J Med       Date:  1971-01

7.  A study of the determination of 5-aminolevulinate hydro-lyase (delta-aminolevulinate dehydratase) activity in hemolysates of human erythrocytes.

Authors:  H B Collier
Journal:  Clin Biochem       Date:  1971-12       Impact factor: 3.281

8.  Hereditary tyrosinaemia. Clinical, enzymatic, and pathological study of an infant with the acute form of the disease.

Authors:  N A Carson; J D Biggart; A H Bittles; D Donovan
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

9.  Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.

Authors:  D T Whelan; V G Zannoni
Journal:  Biochem Med       Date:  1974-01

10.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  1 in total

1.  Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).

Authors:  R M Tanguay; J P Valet; A Lescault; J L Duband; C Laberge; F Lettre; M Plante
Journal:  Am J Hum Genet       Date:  1990-08       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.